Responses
Late-Breaking Abstracts
Combination Immunotherapies
962 Integrative immunomics highlight the immunomodulatory impact of neoadjuvant chemotherapy and immune-based treatments in resected non-small-cell lung cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.